SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection.
Trial details
- Registry ID
- NCT05461170
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection.NCT05461170 | VIR | Phase 2 | Active not recruiting | 2031-11Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |